Sidney J. Winawer, MD
Requests for Single Reprints: Sidney J. Winawer, MD, Gastroenterology and Nutrition Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; e-mail, email@example.com.
Winawer S.; Screening Sigmoidoscopy: Can the Road to Colonoscopy Be Less Traveled?. Ann Intern Med. 2003;139:1034-1035. doi: 10.7326/0003-4819-139-12-200312160-00013
Download citation file:
Published: Ann Intern Med. 2003;139(12):1034-1035.
Since 1997, there has been a consensus that screening is effective in reducing colorectal cancer mortality and is cost-effective (1-4). Colorectal cancer screening has now become the standard of medical practice, and failure to screen has become a basis for malpractice suits. Guidelines suggest a 1- or a 2-stage screening approach. The 1-stage approach is to screen average-risk men and women with colonoscopy every 10 years. This “1-stop shopping” strategy can screen, diagnose, and treat by removing premalignant adenomatous polyps. The 2-stage approach requires people to have an annual fecal occult blood test (FOBT), flexible sigmoidoscopy every 5 years, or both, followed by colonoscopy if the FOBT result is positive or a polyp is present on sigmoidoscopy. More sensitive guaiac-based FOBTs, newer immunochemical FOBTs (5), and a test for stool DNA mutations have expanded available options for detecting neoplasia. Virtual colonoscopy detects polyps or cancer by reconstructing computed tomographic images (1).
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only